Why is Kobo Biotech falling/rising?

As of 26-Jun, Kobo Biotech Ltd's stock price is currently at Rs 2.42, reflecting a decrease of Rs 0.09 or 3.59%. The stock has recently underperformed its sector by 4.1% and is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has declined by 3.97%, and it has seen a significant drop of 40.25% over the last year. The company has not declared results in the last six months, contributing to its weak long-term fundamental strength, with net sales declining at an annual rate of 100%. Additionally, the stock's recent performance includes the lowest quarterly figures for PBDIT, PBT, and EPS, further highlighting its struggles.
In the broader market context, the Sensex has shown a positive return of 2.94% over the past week, contrasting sharply with Kobo Biotech's decline. This disparity underscores the stock's underperformance relative to the market, as it has consistently lagged behind the BSE 500 over various time frames, including the last three years and one year. Despite a rise in investor participation, as indicated by a 94.27% increase in delivery volume, the overall sentiment remains negative due to the company's high debt levels and poor growth prospects, making it a risky investment at this time.